You can find more information about 1-Cys Prxox using the following links:

PFID

PFID Old

Formal Annotation

PlasmoDB

TDR Targets

Subcellular Localization

Affecting Drugs

Drug Name

PubMed Articles (year of publication)

PF3D7_0304500

PFC0205c

1-cys-glutaredoxin-like protein-1

iodoacetamide	Plasmodium falciparum possesses a classical glutaredoxin and a second, glutaredoxin-like protein with a PICOT homology domain
S-nitrosoglutathione	Plasmodium falciparum possesses a classical glutaredoxin and a second, glutaredoxin-like protein with a PICOT homology domain
Structural, stability and physicochemical properties, suggested target	Structural and stability characteristics of a monothiol glutaredoxin: glutaredoxin-like protein 1 from Plasmodium falciparum

PF3D7_0709200

PF07_0036

Cg6 protein glutaredoxin-like protein

PF3D7_0729200

MAL7P1.159

1-cys peroxiredoxin

Auranofin	New leads for drug repurposing against malaria
Suggested target	The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs

PF3D7_0802200

PF08_0131

1-cys peroxiredoxin

Arthemeter	Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria
Doxycycline	Plasmodium falciparum proteome changes in response to doxycycline treatment
Mercaptosuccinate	Homology modeling and docking mechanism of the mercaptosuccinate and methotrexate to P. falciparum 1-Cys peroxiredoxin: a preliminary molecular study
Methotrexate	Homology modeling and docking mechanism of the mercaptosuccinate and methotrexate to P. falciparum 1-Cys peroxiredoxin: a preliminary molecular study
Methylgene_05	Identification of potential multitarget antimalarial drugs
Paraquat	2-Cys peroxiredoxin of Plasmodium falciparum is involved in resistance to heat stress of the parasite
Sodium nitroprusside	2-Cys peroxiredoxin of Plasmodium falciparum is involved in resistance to heat stress of the parasite
Suggested target	Crystal structure of a novel Plasmodium falciparum 1-Cys peroxiredoxin The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs